Health Care/Hospital
Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to its CD30 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory CD30-positive Classical Hodgkin Lymphoma
SINGAPORE, Feb. 27, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced that the Company's investigational CD30-directed autologous chimeric antigen receptor T cell (CD30 CAR-T) therapy has been gran...
2020-02-27 20:00
2019
Studycat Donates Free Use of Its Children's Language Learning Apps Globally
HONG KONG, Feb. 27, 2020 /PRNewswire/ -- Global edtech firm Studycat Limited
2020-02-27 19:14
2330
European Medicines Agency accepts submission of GSK's Marketing Authorisation Application for Zejula (niraparib) in first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer
- Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status LONDON, Feb. 27, 2020 /PRNewswire/ -- GlaxoSmithKline plc announced that the European M...
2020-02-27 17:00
1308
Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect
SONGDO, South Korea, Feb. 24, 2020 /PRNewswire/ -- Samsung Biologics has been monitoring the COVID-19 situation closely since the initial outbreak in late January and taking proactive measures company-wide to ensure a safe working environment and continuous business operations. The company confi...
2020-02-27 15:49
1361
WuXi Diagnostics' integrated testing solution for COVID-19 epidemiological investigation and diagnosis
SHANGHAI, Feb. 27, 2020 /PRNewswire/ -- WuXi Diagnostics has successfully developed a series of COVID-19 detection products, including2019-nCoV IgM Detection kit (Enzyme-linked Immunoassay, ELISA), 2019-nCoV IgM/IgG Detection Kit (Enzyme-linked Immunoassay, ELISA) and 2019-nCoV Nucleic Acid Detec...
2020-02-27 15:47
1734
Country Garden Delivered 100,000 Protective Suits Directly from Sydney to Wuhan to Support Healthcare Workers
FOSHAN, China, Feb. 27, 2020 /PRNewswire/ -- On February 24, 2020, nearly 100,000 protective suits purchased by Country Garden Holdings (HK:2007) through the Guoqiang Foundation were delivered directly fromSydney, Australia to Wuhan via a chartered airplane. Along with supplies and equipment d...
2020-02-27 11:24
8783
Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
HANGZHOU and SHAOXING, China, Feb. 27, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today the advancement in Novel Coronavirus Pneumonia clinical trial of oral Ganovo® and Ritonavir combination therapy, led by Dr. Hongyi CHEN, the director of the Ninth Hospital ofNanchang...
2020-02-27 08:00
3448
Pertubuhan Integriti Nicky Liow Malaysia & Yayasan Winner Emperor Sedunia Donates 76,920 Masks and Medical Supplies to Covid-19 Infected China Witnessed by Local Celebrities
KUALA LUMPUR, Malaysia, Feb. 27, 2020 /PRNewswire/ -- Dato' Sri Liow Soon Hee through his charity foundations, Pertubuhan Integriti Nicky Liow Malaysia and Yayasan Winner Emperor Sedunia, along with the support of local Malaysian celebrityExcella Chong, singer-songwriter, has donated shipments of...
2020-02-27 08:00
7850
New VITROS® XT 3400 Chemistry System from Ortho Clinical Diagnostics Enhances Its VITROS® XT Solutions, Offering Labs Faster, More Accurate Results and Trusted System Reliability to Ensure Better Patient Outcomes
RARITAN, N.J., Feb. 27, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the VITROS® XT 3400 Chemistry System, which completes th...
2020-02-27 01:40
1986
Global Pharmaceutical Contract Manufacturing Organization Market to Reach $102.14 Billion by 2024
Advancements in flexible manufacturing technology to help address new demand in personalized medicine, finds Frost & Sullivan SANTA CLARA, California, Feb. 27, 2020 /PRNewswire/ -- Contract manufacturing organizations (CMOs) are currently transitioning from transactional relationships to strateg...
2020-02-27 01:28
1328
China counters economic fallout from coronavirus
BEIJING, Feb. 26, 2020 /PRNewswire/ -- A news report by China.org.cn on China's economy outlook under the influence of COVID-19:   Lockdowns, travel restrictions, shops and movie theaters closed, business operations delayed, and migrant workers stranded in their hometowns. These...
2020-02-26 22:00
1156
Optoelectronic Technologies Assisting in the Fight Against COVID-19
SHENZHEN, China, Feb. 26, 2020 /PRNewswire/ -- Optoelectronic technologies benefit our daily lives from every aspect. However less people know that optoelectronic technologies are playing a key role amid the fight against COVID-19, especially for technologies such as information and communication...
2020-02-26 16:57
2099
Enso Partners with My Life Centre to Open 2 More ECP Centres
KUALA LUMPUR, Malaysia, Feb. 26, 2020 /PRNewswire/ -- Enso S&A Health House Sdn. Bhd. (Enso) has just enter into a partnership with My Life Centre (MLC) to open 2 more new ECPCentres in Johor Bahru & Kota Bahru for alternative medicine and therapy. Approximately 3 months ago, Enso took over "The ...
2020-02-26 16:30
4345
The Animal Health & Feed Zone of CPhI China 2020 to be held in Shanghai
SHANGHAI, Feb. 26, 2020 /PRNewswire/ -- The Animal Health & Feed Zone of CPhI China to be held at the Shanghai New International Expo Centre (SNIEC) fromJune 22-24, 2020 will focus on top concerns of animal health enterprises. 90% of the total antibiotics in the world are consumed in food-source...
2020-02-26 11:49
1850
KAHR Medical Raises $18 Million in Private Funding Round
Funds will be used for advancing the Company's next generation immuno-oncology
drug candidates, including lead anti-CD47 product for the treatment of solid
tumors through Phase I/II study in addition to advancing preclinical pipeline
JERUSALEM, Feb. 26, 2020 /PRNewswire/ -- KAHR Medical
2020-02-26 08:30
2413
Trip.com Announces Safeguards for Travelers Affected by COVID-19 Outbreak
SHANGHAI, Feb. 26, 2020 /PRNewswire/ -- In light of the ongoing impact of the COVID-19 outbreak, Trip.com today announced an expansion to its Safeguard Cancellation Guarantee. Originally announced in January with the support of industry partners, the Trip.com Safeguard Cancellation Guarantee ini...
2020-02-26 01:44
1818
New Data Confirms Cardiac Dimensions' Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation
Pooled Analysis of Prospective Studies Presented during Late Breaking Trials Session at CRT 2020 KIRKLAND, Washington, Feb. 25, 2020 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients ...
2020-02-26 00:50
1078
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
SAN FRANCISCO and SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Vir Biotechnology, Inc. ("Vir") (Nasdaq: VI...
2020-02-25 21:30
2300
China Xiangtai Food Co., Ltd. Entered into Business Collaboration Agreement for up to RMB35,000,000 to Expand Operation Scale and Diversify Distribution Channels
CHONGQING, China, Feb. 25, 2020 /PRNewswire/ -- China Xiangtai Food Co. Ltd. (NASDAQ: PLIN) (the "Company" or the "PLIN"), an emerging growth company primarily engaged in pork processing inChina, today announced that the Company, through its primary operating subsidiary Chongqing Penglin Food Co....
2020-02-25 21:30
5791
Connect Biopharma Enhances its Intellectual Property Estate for CBP-307, a Targeted Therapy with Potential in Multiple Autoimmune Diseases, with Patent Issuances in the United States, EU, Japan and Australia
Novel, next-generation S1P1 agonist currently in Phase 2 clinical development for treatment of inflammatory bowel disease SAN DIEGO and TAICANG, China, Feb. 25, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and spe...
2020-02-25 21:00
914
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 272 media titles]
2024-04-24 17:09
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9195
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7769
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
4889
